Avadel Pharmaceuticals plc (AVDL) Earnings History
Net Loss29 years of earnings data (1996–2024) · Currently unprofitable on a TTM basis
Loading earnings history...
Avadel Pharmaceuticals plc (AVDL) Earnings Overview
As of June 22, 2026, Avadel Pharmaceuticals plc (AVDL) reported trailing twelve-month net income of -$278,000, reflecting +74.5% year-over-year growth. The company earned $-0.00 per diluted share over the past four quarters, with a net profit margin of -28.9%.
Looking at the long-term picture, AVDL's historical earnings data spans multiple years. The company achieved its highest annual net income of $67M in fiscal 2017.
Avadel Pharmaceuticals plc is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including JAZZ ($29M net income, -8.3% margin), AXSM (-$188M net income, -28.7% margin), INVA ($504M net income, 63.8% margin), AVDL has room to improve margins relative to the peer group. Compare AVDL vs JAZZ →
AVDL Earnings vs Peers
Earnings metrics vs comparable public companies
AVDL Historical Earnings Data (1996–2024)
29 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$49M | +69.5% | -$42M | $-0.51 | -28.9% | -25.1% |
| 2023 | -$160M | -16.6% | -$138M | $-2.00 | -573.2% | -493.0% |
| 2022 | -$137M | -77.8% | -$99M | $-2.29 | - | - |
| 2021 | -$77M | -1200.3% | -$86M | $-1.32 | - | - |
| 2020 | $7M | +121.2% | $6M | $0.13 | 31.5% | 26.0% |
| 2019 | -$33M | +65.1% | -$24M | $-0.89 | -56.1% | -40.7% |
| 2018 | -$95M | -241.7% | -$105M | $-2.55 | -92.3% | -101.6% |
| 2017 | $67M | +262.9% | $88M | $1.61 | 38.9% | 51.1% |
| 2016 | -$41M | -201.5% | -$5M | $-1.00 | -27.5% | -3.3% |
| 2015 | $41M | +147.9% | $71M | $0.93 | 23.5% | 41.2% |
| 2014 | -$85M | -97.8% | -$94M | $-2.34 | -574.7% | -635.2% |
| 2013 | -$43M | -1229.8% | -$50M | $-1.69 | -191.3% | -222.9% |
| 2012 | -$3M | +63.2% | -$3M | $-0.13 | -12.4% | -13.4% |
| 2011 | -$9M | +2.2% | -$10M | $-0.36 | -26.9% | -29.4% |
| 2010 | -$9M | +21.5% | -$10M | $-0.37 | -24.2% | -26.5% |
| 2009 | -$11M | +5.3% | -$12M | $-0.47 | -27.2% | -27.9% |
| 2008 | -$12M | +68.0% | -$20M | $-0.50 | -31.3% | -52.2% |
| 2007 | -$38M | -7.2% | -$41M | $-1.57 | -103.0% | -111.4% |
| 2006 | -$35M | -28.6% | -$39M | $-1.48 | -152.9% | -168.7% |
| 2005 | -$27M | -319.0% | -$41M | $-1.19 | -116.0% | -172.8% |
| 2004 | $12M | +457.7% | $9M | $0.53 | 22.6% | 15.9% |
| 2003 | -$3M | -216.3% | -$5M | $-0.20 | -13.9% | -18.7% |
| 2002 | $3M | +204.6% | $-223,000 | $0.18 | 16.3% | -1.2% |
| 2001 | -$3M | +69.6% | -$3M | $-0.18 | -22.0% | -24.1% |
| 2000 | -$9M | -41.3% | -$16M | $-0.62 | -86.8% | -147.7% |
| 1999 | -$7M | +14.3% | -$7M | $-0.52 | -60.6% | -63.4% |
| 1998 | -$8M | -14.9% | -$9M | $-0.65 | -82.0% | -97.6% |
| 1997 | -$7M | +1.4% | -$9M | $-0.65 | -84.0% | -111.1% |
| 1996 | -$7M | - | -$9M | $-0.80 | -140.8% | -183.7% |
Download Data
Export AVDL earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
30+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
AVDL — Frequently Asked Questions
Quick answers to the most common questions about buying AVDL stock.
What is AVDL earnings per share (EPS)?
AVDL trailing twelve-month (TTM) diluted EPS is $-0.00, reflecting +74.5% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 1996 to 2024 is available in the table on this page.
What is Avadel Pharmaceuticals plc's net income?
Avadel Pharmaceuticals plc (AVDL) trailing twelve-month net income is $-278000.00 as of 2024. Earnings grew +74.5% year-over-year.
Is AVDL profitable?
AVDL is not currently profitable on a TTM basis, reporting a net loss of $-278000.00. Net margin is -28.9%. Investors should monitor for a return to profitability.
What is AVDL's earnings growth rate?
AVDL compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 1996 to 2024.
What are AVDL's profit margins?
Avadel Pharmaceuticals plc net profit margin is -28.9%, operating margin is -25.1%, and gross margin is +91.0%. Below-average margins reflect competitive or cost pressures. Return on Equity is -60.4%.
Is AVDL growing earnings?
Yes, AVDL earnings are accelerating — EPS growth of +74.5% exceeds the 5-year CAGR of N/A. TTM net income reached $-278000.00. Earnings momentum is strengthening.
What was AVDL's best earnings year?
Avadel Pharmaceuticals plc's highest annual net income on record is $67M, achieved in fiscal year 2017. Earnings history on this page spans 1996 to 2024 and includes all annual and quarterly figures.
What were AVDL's earnings last quarter?
AVDL's most recent reported quarter was Q3 2025. Net income was $20000.00 with diluted EPS of $0.00. For a full breakdown of all quarters, see the quarterly earnings table on this page.